Page last updated: 2024-08-23

triamcinolone and Diabetic Retinopathy

triamcinolone has been researched along with Diabetic Retinopathy in 67 studies

Research

Studies (67)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	25 (37.31)	29.6817
2010's	35 (52.24)	24.3611
2020's	7 (10.45)	2.80

Authors

Authors	Studies
Bonifazzi, C; Parmeggiani, F; Sorrentino, FS	1
Erdogan, G; Gumus, G; Gunay, BO; Karatas Durusoy, G	1
Du, S; Jiang, F; Wang, H; Wang, Y	1
Li, T; Mir, TA; Rittiphairoj, T; Virgili, G	1
Kankaanpää, E; Pesonen, M; Vottonen, P	1
An, JH; Kim, YC	1
Barnes, R; Barry, R; Barthelmes, D; Bhandari, S; Gillies, M; Nguyen, V; Squirrell, D; Tan, T; Wang, N; Wells, JM	1
Evans, JR; Gordon, I; Lucenteforte, E; Parravano, M; Virgili, G	2
Eldem, B; Kadayıfçılar, S; Koç, İ	1
Karst, S; Mitsch, C; Schmidt-Erfurth, U; Scholda, C	1
Campain, A; Fraser-Bell, S; Gillies, MC; Hennings, C; Mehta, H; Nguyen, V	1
Kester, E; Shaikh, S; Zarifa, R	1
Beardsley, RM; Flaxel, CJ; Messenger, WB	1
Enns, EA; Goldhaber-Fiebert, JD; Matesic, B; Owens, DK; Pershing, S	1
Evans, JR; Menchini, F; Parravano, M; Virgili, G	1
Sobaci, G; Yolcu, Ü	1
Baquero-Aranda, I; García-Basterra, I; García-Campos, JM; Kamal-Salah, R	1
Ah-Kee, EY; Chew, N; Chia, SN; Gupta, M; Lim, LT	1
Baillif, S; Gastaud, P; Landré, C; Zourdani, A	1
Ercalik, NY; Imamoglu, S; Kumral, ET; Vural, ET; Yenerel, NM	1
Amsden, BG; Marecak, D	1
Gao, Y; Lan, J; Wang, W; Xie, L; Zhang, L	1
Bringmann, A; Hollborn, M; Iandiev, I; Pannicke, T; Reichenbach, A; Wiedemann, P; Wurm, A; Zimmermann, H	1
Azen, SP; Chung, EJ; Freeman, WR; Koh, HJ; Lee, H	1
Gariano, RF; Paulus, YM	1
Bhurayanontachai, P; Ma-a-lee, A; Ratanasukon, M	1
Menchini, F; Parravano, M; Virgili, G	1
Al Saeidi, R; Haritoglou, C; Kook, D; Kreutzer, TC; Neubauer, AS; Ulbig, MW; Wolf, A	1
Gatzioufas, Z; Hille, K; Khurieva-Sattler, E; Krause, M; Löw, U; Ruprecht, K; Seitz, B; Toropygin, S	1
Cennamo, G; Cennamo, GL; D'Amico, G; de Crecchio, G; Farese, E; Finelli, M; Forte, R; Nicoletti, G	1
Gerding, H; Hefner, L; Loukopoulos, V; Meier, C; Riese, J; Timmermann, M	1
Cho, WB; Kim, HC; Moon, JW	1
Joussen, AM; Kakkassery, V; Winterhalter, S	1
Cordero-Coma, M; Gallagher, MJ; Lavaque, AJ; Padula, WV; Yilmaz, T	1
Giuliari, G	1
Synek, S; Vojniković, B	1
Eneh, A; Gale, J; Schweitzer, KD	1
Koch, F; Koss, MJ; Naser, H; Singh, P	1
Synek, S; Veselý, P	1
Bakiah, S; Norlaili, M; Zunaina, E	1
Chan, CK; Lai, TY; Lam, DS; Lee, VY; Li, CL; Liu, DT; Mohamed, S	1
Stewart, MW	1
Ignat, F; Irimia, A	1
Brunetti, M; Menchini, F; Parravano, M; Virgili, G	1
Cetin, EN; Yıldırım, C	1
Baek, SU; Kwon, SI; Park, IW	1
Ip, MS	1
Gupta, R; Negi, A; Vernon, SA	1
Afzal, A; Brooks, HL; Butler, JM; Caballero, S; Grant, MB; Guthrie, SM; Koc, M; Mames, RN; Scott, EW; Segal, MS	1
Pastor Jimeno, JC	1
Domínguez, A	1
Erkiliç, K; Evereklioglu, C; Oner, A; Ozkiris, A	1
Gandorfer, A; Haritoglou, C; Priglinger, S	1
Haritoglou, C; Kampik, A	1
Behar-Cohen, F; Iossifov, D; Metge, F; Miyamoto, N	1
Ahmadieh, H; Ramezani, A; Tabatabaei, H	1
Sato, S; Yamamoto, T; Yamashita, H	1
Li Yim, JF; Murdoch, JR	1
Gillies, MC; Islam, FM; Larsson, J; Wong, TY; Zhu, M	1
Cleary, PE; Gibran, SK; Jungkim, S; Khan, K	1
He, YG; Kramar, M; Vu, L; Whitson, JT	1
Park, KH; Sohn, JH; Song, SJ	1
Alfaro, DV; Fernández, M; Gómez-Ulla, F; Marticorena, J; Méndez, ER; Rothen, M	1
Kumar, A; Sinha, S	1
Chong, CC; Grover, D; Li, TJ	1
Chacón-Lara, A; Hernández-Da Mota, SE; Hernández-Vázquez, E	1

Reviews

20 review(s) available for triamcinolone and Diabetic Retinopathy

Article	Year
Intravitreal steroids for macular edema in diabetes. The Cochrane database of systematic reviews, 2020, 11-17, Volume: 11 Topics: Anti-Inflammatory Agents; Bevacizumab; Bias; Confidence Intervals; Dexamethasone; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Randomized Controlled Trials as Topic; Ranibizumab; Steroids; Triamcinolone; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body	2020
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. The Cochrane database of systematic reviews, 2017, 06-22, Volume: 6 Topics: Angiogenesis Inhibitors; Aptamers, Nucleotide; Bevacizumab; Diabetic Retinopathy; Humans; Laser Coagulation; Macular Edema; Network Meta-Analysis; Quality of Life; Randomized Controlled Trials as Topic; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Triamcinolone; Vascular Endothelial Growth Factor A; Visual Acuity	2017
Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema. The Cochrane database of systematic reviews, 2018, 04-18, Volume: 4 Topics: Bevacizumab; Dexamethasone; Diabetic Retinopathy; Drug Therapy, Combination; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macula Lutea; Macular Edema; Randomized Controlled Trials as Topic; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Triamcinolone; Vascular Endothelial Growth Factor A; Visual Acuity	2018
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. The Cochrane database of systematic reviews, 2018, 10-16, Volume: 10 Topics: Angiogenesis Inhibitors; Aptamers, Nucleotide; Bevacizumab; Diabetic Retinopathy; Humans; Laser Coagulation; Macular Edema; Network Meta-Analysis; Quality of Life; Randomized Controlled Trials as Topic; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Triamcinolone; Vascular Endothelial Growth Factor A; Visual Acuity	2018
Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema. Drug design, development and therapy, 2013, Volume: 7 Topics: Dexamethasone; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Humans; Intraocular Pressure; Light Coagulation; Macular Edema; Quality of Life; Triamcinolone; Vascular Endothelial Growth Factor A; Vitrectomy	2013
Anti-vascular endothelial growth factor for diabetic macular oedema. The Cochrane database of systematic reviews, 2014, Oct-24, Issue:10 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Diabetic Retinopathy; Humans; Laser Coagulation; Macular Edema; Randomized Controlled Trials as Topic; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Triamcinolone; Vascular Endothelial Growth Factor A	2014
Advances in the management of diabetic macular oedema based on evidence from the Diabetic Retinopathy Clinical Research Network. Singapore medical journal, 2015, Volume: 56, Issue:5 Topics: Adrenal Cortex Hormones; Bevacizumab; Biomedical Research; Diabetic Retinopathy; Disease Management; Disease Progression; Humans; Light Coagulation; Macular Edema; Ranibizumab; Retina; Tomography, Optical Coherence; Triamcinolone; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy	2015
The Efficacy and Safety of Current Treatments in Diabetic Macular Edema: A Systematic Review and Network Meta-Analysis. PloS one, 2016, Volume: 11, Issue:7 Topics: Diabetic Retinopathy; Humans; Intravitreal Injections; Laser Therapy; Macular Edema; Network Meta-Analysis; Patient Safety; Randomized Controlled Trials as Topic; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Treatment Outcome; Triamcinolone; Visual Acuity	2016
Diabetic retinopathy: a growing concern in an aging population. Geriatrics, 2009, Volume: 64, Issue:2 Topics: Aged; Aged, 80 and over; Aging; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Blindness; California; Diabetic Retinopathy; Drug Therapy, Combination; Geriatrics; Glucocorticoids; Humans; Incidence; Injections, Intralesional; Laser Coagulation; Mass Screening; Randomized Controlled Trials as Topic; Ranibizumab; Risk Factors; Treatment Outcome; Triamcinolone	2009
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema. The Cochrane database of systematic reviews, 2009, Oct-07, Issue:4 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Diabetic Retinopathy; Humans; Macular Edema; Randomized Controlled Trials as Topic; Triamcinolone; Vascular Endothelial Growth Factor A	2009
[Anti-VEGF inhibitors and their role in the treatment of diabetic macular oedema]. Klinische Monatsblatter fur Augenheilkunde, 2010, Volume: 227, Issue:9 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Blood-Retinal Barrier; Capillary Permeability; Clinical Trials as Topic; Combined Modality Therapy; Diabetic Retinopathy; Fluorescein Angiography; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Middle Aged; Off-Label Use; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinoscopy; Triamcinolone; Vascular Endothelial Growth Factor A	2010
Triamcinolone and intraocular sustained-release delivery systems in diabetic retinopathy. Current pharmaceutical biotechnology, 2011, Mar-01, Volume: 12, Issue:3 Topics: Anti-Inflammatory Agents; Blood-Retinal Barrier; Delayed-Action Preparations; Diabetic Retinopathy; Drug Delivery Systems; Eye; Humans; Injections, Intraocular; Intravitreal Injections; Macular Edema; Randomized Controlled Trials as Topic; Triamcinolone; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body	2011
Corticosteroid use for diabetic macular edema: old fad or new trend? Current diabetes reports, 2012, Volume: 12, Issue:4 Topics: Anti-Inflammatory Agents; Dexamethasone; Diabetic Retinopathy; Drug Administration Schedule; Drug Implants; Female; Fluocinolone Acetonide; Humans; Intravitreal Injections; Macular Edema; Male; Triamcinolone; Visual Acuity	2012
[Treatment in diabetic maculopathy]. Oftalmologia (Bucharest, Romania : 1990), 2011, Volume: 55, Issue:4 Topics: Angiogenesis Inhibitors; Diabetic Retinopathy; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Lasers, Gas; Light Coagulation; Macular Edema; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Triamcinolone; Vitrectomy	2011
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema. The Cochrane database of systematic reviews, 2012, Dec-12, Volume: 12 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Diabetic Retinopathy; Humans; Laser Coagulation; Macular Edema; Randomized Controlled Trials as Topic; Ranibizumab; Triamcinolone; Vascular Endothelial Growth Factor A	2012
Adjuvant treatment modalities to control macular edema in diabetic patients undergoing cataract surgery. International ophthalmology, 2013, Volume: 33, Issue:5 Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Cataract; Chemotherapy, Adjuvant; Diabetic Retinopathy; Disease Progression; Humans; Intravitreal Injections; Macular Edema; Phacoemulsification; Ranibizumab; Triamcinolone	2013
Intravitreal injection of triamcinolone: an emerging treatment for diabetic macular edema. Diabetes care, 2004, Volume: 27, Issue:7 Topics: Anti-Inflammatory Agents; Diabetic Retinopathy; Humans; Macular Edema; Triamcinolone	2004
[Diabetic retinopathy-state of arts of diagnosis and treatment]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Sep-28, Volume: Suppl 3 Topics: Diabetic Retinopathy; Diagnosis, Differential; Fluorescein Angiography; Humans; Hypoglycemic Agents; Light Coagulation; Tomography, Optical Coherence; Triamcinolone; Vitrectomy	2006
Intravitreal triamcinolone for the treatment of diabetic macular edema. Current diabetes reviews, 2006, Volume: 2, Issue:1 Topics: Anti-Inflammatory Agents; Diabetic Retinopathy; Half-Life; Humans; Laser Coagulation; Macular Edema; Triamcinolone; Vitreous Body	2006
Intravitreal steroids for macular edema in diabetes. The Cochrane database of systematic reviews, 2008, Jan-23, Issue:1 Topics: Anti-Inflammatory Agents; Dexamethasone; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Injections; Macular Edema; Randomized Controlled Trials as Topic; Steroids; Triamcinolone; Visual Acuity; Vitreous Body	2008

Trials

11 trial(s) available for triamcinolone and Diabetic Retinopathy

Article	Year
Real-World Results of Intravitreal Ranibizumab, Bevacizumab, or Triamcinolone for Diabetic Macular Edema. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2018, Volume: 239, Issue:2-3 Topics: Angiogenesis Inhibitors; Bevacizumab; Diabetic Retinopathy; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity	2018
Comparison of combination posterior sub-tenon triamcinolone and modified grid laser treatment with intravitreal triamcinolone treatment in patients with diffuse diabetic macular edema. Yonsei medical journal, 2008, Dec-31, Volume: 49, Issue:6 Topics: Adult; Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Fovea Centralis; Humans; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Triamcinolone; Visual Acuity; Vitreous Body	2008
[Comparison of pars plana vitrectomy with ILM peeling and intravitreal triamcinolone in diffuse diabetic macular oedema]. Klinische Monatsblatter fur Augenheilkunde, 2010, Volume: 227, Issue:6 Topics: Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Humans; Macular Edema; Male; Middle Aged; Triamcinolone; Vitrectomy; Vitreous Body	2010
[Focal laser photocoagulation in patients with diabetic macular edema after pretreatment with triamcinolone: 6-month results]. Klinische Monatsblatter fur Augenheilkunde, 2010, Volume: 227, Issue:4 Topics: Aged; Anti-Inflammatory Agents; Combined Modality Therapy; Diabetic Retinopathy; Female; Humans; Laser Coagulation; Macular Edema; Male; Premedication; Treatment Outcome; Triamcinolone	2010
Intravitreal triamcinolone and bevacizumab as adjunctive treatments to panretinal photocoagulation in diabetic retinopathy. The British journal of ophthalmology, 2010, Volume: 94, Issue:7 Topics: Adolescent; Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Chemotherapy, Adjuvant; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections, Intraocular; Laser Coagulation; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone; Vascular Endothelial Growth Factor A; Vision Disorders; Visual Acuity; Young Adult	2010
Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema. Collegium antropologicum, 2010, Volume: 34 Suppl 2 Topics: Adult; Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Treatment Outcome; Triamcinolone	2010
Intravitreal Bevacizumab with or without triamcinolone for refractory diabetic macular oedema. Collegium antropologicum, 2011, Volume: 35, Issue:3 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Triamcinolone	2011
Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema--a comparative pilot study. BMC ophthalmology, 2011, Nov-23, Volume: 11 Topics: Adult; Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Pilot Projects; Severity of Illness Index; Triamcinolone; Visual Acuity	2011
Intravitreal triamcinolone reinjection for refractory diabetic macular edema. Korean journal of ophthalmology : KJO, 2006, Volume: 20, Issue:3 Topics: Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Prospective Studies; Retreatment; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body	2006
Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema. The British journal of ophthalmology, 2007, Volume: 91, Issue:10 Topics: Aged; Cataract Extraction; Diabetic Retinopathy; Drug Administration Schedule; Female; Glucocorticoids; Humans; Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body	2007
[Use of triamcinolone and bevacizumab in 25G phaco-vitrectomy surgery for the treatment of cataract and diabetic macular edema]. Archivos de la Sociedad Espanola de Oftalmologia, 2008, Volume: 83, Issue:5 Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Cataract; Combined Modality Therapy; Diabetic Retinopathy; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Phacoemulsification; Prospective Studies; Triamcinolone; Vitrectomy	2008

Other Studies

36 other study(ies) available for triamcinolone and Diabetic Retinopathy

Article	Year
Diabetic macular edema: Safe and effective treatment with intravitreal triamcinolone acetonide (Taioftal). PloS one, 2021, Volume: 16, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Humans; Intravitreal Injections; Italy; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone	2021
Comparison of Intravitreal Dexamethasone Implant and Posterior Subtenon Triamcinolone Injection in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2022, Volume: 245, Issue:5 Topics: Dexamethasone; Diabetes Mellitus; Diabetic Retinopathy; Drug Implants; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Retrospective Studies; Treatment Outcome; Triamcinolone; Visual Acuity	2022
Diabetic Retinopathy Analysis-Effects of Nanoparticle-Based Triamcinolone. Journal of nanoscience and nanotechnology, 2020, 10-01, Volume: 20, Issue:10 Topics: Animals; Diabetes Mellitus; Diabetic Retinopathy; Drug Carriers; Lipids; Mice; Nanoparticles; Nanostructures; Particle Size; Triamcinolone	2020
Cost-effectiveness of dexamethasone and triamcinolone for the treatment of diabetic macular oedema in Finland: A Markov-model. Acta ophthalmologica, 2021, Volume: 99, Issue:7 Topics: Aged; Cost-Benefit Analysis; Dexamethasone; Diabetic Retinopathy; Disease Progression; Finland; Follow-Up Studies; Glucocorticoids; Health Care Costs; Humans; Macular Edema; Markov Chains; Quality-Adjusted Life Years; Time Factors; Treatment Outcome; Triamcinolone; Visual Acuity	2021
Difference in the efficacy of intravitreal dexamethasone implant before and after silicone oil removal: A case report. Medicine, 2021, Mar-19, Volume: 100, Issue:11 Topics: Aged; Device Removal; Dexamethasone; Diabetic Retinopathy; Drug Implants; Humans; Intravitreal Injections; Macular Edema; Male; Retinal Detachment; Silicone Oils; Triamcinolone; Vascular Endothelial Growth Factors; Vitrectomy	2021
Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! Registry. Eye (London, England), 2022, Volume: 36, Issue:3 Topics: Angiogenesis Inhibitors; Bevacizumab; Blindness; Diabetes Mellitus; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Ranibizumab; Registries; Retrospective Studies; Treatment Outcome; Triamcinolone; Vascular Endothelial Growth Factor A	2022
Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment - reply to the letter to the editor. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2018, Volume: 256, Issue:5 Topics: Angiogenesis Inhibitors; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Ranibizumab; Retina; Treatment Outcome; Triamcinolone; Vascular Endothelial Growth Factor A	2018
Peristence of triamcinolone crystals after intra-vitreal injection: benign crystalline hyaloidopathy. Indian journal of ophthalmology, 2013, Volume: 61, Issue:4 Topics: Anti-Inflammatory Agents; Crystallization; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Triamcinolone	2013
Cost-effectiveness of treatment of diabetic macular edema. Annals of internal medicine, 2014, Jan-07, Volume: 160, Issue:1 Topics: Administration, Ophthalmic; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Cost-Benefit Analysis; Diabetic Retinopathy; Disease Progression; Female; Humans; Laser Therapy; Macular Edema; Male; Markov Chains; Middle Aged; Quality-Adjusted Life Years; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Treatment Outcome; Triamcinolone; Vascular Endothelial Growth Factor A; Visual Acuity	2014
The effect of combined treatment of bevacizumab and triamcinolone for diabetic macular edema refractory to previous intravitreal mono-injections. International ophthalmology, 2015, Volume: 35, Issue:1 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retina; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity	2015
Retinal pseudoangiitis after intravitreal triamcinolone. BMJ case reports, 2015, Feb-12, Volume: 2015 Topics: Adult; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intravitreal Injections; Ophthalmoscopes; Retinal Vasculitis; Triamcinolone; Visual Acuity; Vitrectomy; Vitreous Hemorrhage	2015
[Treatment of postoperative cystoid macular edema (Irvine-Gass syndrome) with dexamethasone 0.7 mg intravitreal implant]. Journal francais d'ophtalmologie, 2016, Volume: 39, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cataract Extraction; Dexamethasone; Diabetic Retinopathy; Drug Evaluation; Drug Implants; Humans; Intravitreal Injections; Macular Edema; Middle Aged; Ocular Hypertension; Postoperative Complications; Ranibizumab; Recurrence; Remission Induction; Retinal Detachment; Retrospective Studies; Treatment Outcome; Triamcinolone; Visual Acuity; Vitrectomy	2016
Combined Intravitreal Ranibizumab and Sub-Tenon Injection of Triamcinolone for the Treatment of Diabetic Macular Edema with Retinal Detachment. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2016, Volume: 32, Issue:4 Topics: Adult; Aged; Diabetic Retinopathy; Female; Humans; Injections, Intraocular; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ranibizumab; Retrospective Studies; Triamcinolone	2016
Long-Term Sustained Release from a Biodegradable Photo-Cross-Linked Network for Intraocular Corticosteroid Delivery. Molecular pharmaceutics, 2016, 09-06, Volume: 13, Issue:9 Topics: Adrenal Cortex Hormones; Caproates; Diabetic Retinopathy; Drug Delivery Systems; Injections, Intraocular; Lactones; Polymers; Triamcinolone	2016
Purinergic receptor activation inhibits osmotic glial cell swelling in the diabetic rat retina. Experimental eye research, 2008, Volume: 87, Issue:4 Topics: Adenosine; Animals; Antigens, CD; Apyrase; Cell Size; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glucocorticoids; Male; Neuroglia; Osmosis; Oxidative Stress; Rats; Rats, Long-Evans; Rats, Wistar; Receptors, Purinergic; Retina; Reverse Transcriptase Polymerase Chain Reaction; Triamcinolone	2008
The response pattern of intravitreal triamcinolone injection for non-AMD macular edema. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2009, Volume: 92, Issue:1 Topics: Adult; Age Factors; Aged; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone	2009
Comparison of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular edema. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2010, Volume: 224, Issue:4 Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Injections, Intraventricular; Macular Edema; Male; Middle Aged; Radiography; Retina; Retrospective Studies; Statistics, Nonparametric; Tomography, Optical Coherence; Triamcinolone; Visual Acuity	2010
Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema. Eye (London, England), 2010, Volume: 24, Issue:8 Topics: Aged; Aged, 80 and over; Analysis of Variance; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female; Fovea Centralis; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone; Visual Acuity	2010
Images in clinical medicine. Intravitreal triamcinolone for diabetic macular edema. The New England journal of medicine, 2010, Dec-09, Volume: 363, Issue:24 Topics: Crystallization; Diabetic Retinopathy; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Retina; Tomography, Optical Coherence; Triamcinolone	2010
Practice patterns of Canadian vitreoretinal specialists in diabetic macular edema treatment. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2011, Volume: 46, Issue:3 Topics: Aneurysm; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Canada; Diabetic Retinopathy; Health Surveys; Humans; Light Coagulation; Macular Edema; Ophthalmology; Professional Practice; Thiazolidinediones; Triamcinolone; Vascular Endothelial Growth Factor A; Vitrectomy	2011
[Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone]. Klinische Monatsblatter fur Augenheilkunde, 2011, Volume: 228, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Diabetic Retinopathy; Female; Fluorescein Angiography; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone; Visual Acuity; Vitrectomy	2011
Combined high-dose sub-tenon triamcinolone, intravitreal bevacizumab, and laser photocoagulation for refractory diabetic macular edema: a pilot study. Retina (Philadelphia, Pa.), 2012, Volume: 32, Issue:4 Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Pilot Projects; Triamcinolone; Visual Acuity	2012
Comparison of natural course, intravitreal triamcinolone and macular laser photocoagulation for treatment of mild diabetic macular edema. International journal of medical sciences, 2013, Volume: 10, Issue:3 Topics: Aged; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intravitreal Injections; Light Coagulation; Low-Level Light Therapy; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone	2013
Severe sub conjunctival haemorrhage following intravitreal triamcinolone for refractory diabetic oedema. Eye (London, England), 2005, Volume: 19, Issue:5 Topics: Aged; Conjunctival Diseases; Diabetic Retinopathy; Eye Hemorrhage; Glucocorticoids; Humans; Injections; Macular Edema; Male; Triamcinolone; Vitreous Body	2005
SDF-1 is both necessary and sufficient to promote proliferative retinopathy. The Journal of clinical investigation, 2005, Volume: 115, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Animals; Antibodies; Cell Movement; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Chemokines, CXC; Diabetic Retinopathy; Humans; Ischemia; Mice; Mice, Inbred C57BL; Middle Aged; Retinal Neovascularization; Titrimetry; Triamcinolone	2005
[The Health Institute Carlos III supports a clinical trial on triamcinolone as part of the Eye Research Network]. Archivos de la Sociedad Espanola de Oftalmologia, 2005, Volume: 80, Issue:2 Topics: Academies and Institutes; Biomedical Research; Clinical Trials as Topic; Diabetic Retinopathy; Glucocorticoids; Humans; Spain; Triamcinolone	2005
[The scientific priorities: recognized or silenced?]. Archivos de la Sociedad Espanola de Oftalmologia, 2005, Volume: 80, Issue:4 Topics: Biomedical Research; Diabetic Retinopathy; Glucocorticoids; Humans; Triamcinolone	2005
Pattern electroretinogram for monitoring the efficacy of intravitreal triamcinolone injection in diabetic macular edema. Documenta ophthalmologica. Advances in ophthalmology, 2004, Volume: 109, Issue:2 Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Electrooculography; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macula Lutea; Macular Edema; Male; Middle Aged; Triamcinolone; Visual Acuity; Vitreous Body	2004
[Circulatory disorders of the retina]. MMW Fortschritte der Medizin, 2005, May-26, Volume: 147, Issue:21 Topics: Anti-Inflammatory Agents; Cooperative Behavior; Diabetic Retinopathy; Family Practice; Humans; Injections; Patient Care Team; Retinal Diseases; Retinal Vessels; Risk Factors; Tomography, Optical Coherence; Triamcinolone; Vitreous Body	2005
[Surgical therapy of diabetic retinopathy]. Klinische Monatsblatter fur Augenheilkunde, 2005, Volume: 222, Issue:4 Topics: Blindness; Blood Glucose; Diabetic Retinopathy; Fluorescein Angiography; Humans; Laser Coagulation; Macular Edema; Retina; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone; Vitreoretinopathy, Proliferative	2005
Early effects of intravitreal triamcinolone on macular edema: mechanistic implication. Ophthalmology, 2006, Volume: 113, Issue:11 Topics: Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Triamcinolone; Vitreous Body	2006
Surgical removal of massive macular hard exudate combined with intravitreal triamcinolone in diabetic maculopathy. Eye (London, England), 2007, Volume: 21, Issue:4 Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macula Lutea; Male; Triamcinolone; Vitreous Body	2007
Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema. Ophthalmology, 2007, Volume: 114, Issue:5 Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Prospective Studies; Retina; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body	2007
The effect of intravitreal triamcinolone on intraocular pressure. Current medical research and opinion, 2007, Volume: 23, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Diabetic Retinopathy; Drug Administration Routes; Drug Administration Schedule; Glaucoma, Open-Angle; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Middle Aged; Retrospective Studies; Risk Factors; Triamcinolone	2007
Evaluation of the efficacy of vitrectomy for persistent diabetic macular edema and associated factors predicting outcome. Korean journal of ophthalmology : KJO, 2007, Volume: 21, Issue:3 Topics: Adult; Aged; Diabetic Retinopathy; Female; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retreatment; Retrospective Studies; Treatment Outcome; Triamcinolone; Vitrectomy; Vitreous Body	2007
Optical coherence tomography. Ophthalmology, 2008, Volume: 115, Issue:2 Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macular Edema; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body	2008